Down-regulation of TRIB3 inhibits the progression of ovarian cancer via MEK/ERK signaling pathway

Table 2 Expression of TRIB3 in different types of ovarian tissue

Group	Cases	Low		High		Positive rate (%)	High Positive rate (%)
Group	Cases	−	+	++	+++	Positive rate (%)	High Positive rate (%)
Malignant	94	23	19	23	29	75.5^a,b	60.6^c,d
Borderline	16	8	4	2	2	50^e,f	25^g,h
Benign	14	9	4	1	0	35.7	7.1
Normal	13	10	3	0	0	23.1	0

^aMalignant vs. benign (**P = 0.004)
^bMalignant vs. normal (***P < 0.001)
^cMalignant vs. benign (***P = 0.001)
^dMalignant vs. normal (***P < 0.001)
^eBorderline vs. benign (P = 0.431)
^fBorderline vs. normal (P = 0.249)
^gBorderline vs. benign (P = 0.336)
^hBorderline vs. normal (P = 0.107)

ISSN: 1475-2867